Skip to content
The Nexus
HEALTHJun 20 · 13:00 UTCTHE ATLANTICNicholas Florko

Are GLP-1s Performance-Enhancing Drugs?

Serena Williams, a paid spokesperson for telehealth company Ro, used GLP-1 weight-loss drugs to lose 34 pounds and claims the medication improved her training and tennis performance. The article explores whether GLP-1s should be classified as performance-enhancing drugs, noting the World Anti-Doping Agency is monitoring their use, though current rules allow athletes to take them.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting